Home Global Health Policy Topics

Global Health Policy

New and Noteworthy

Analysis of USAID’s Active and Terminated Awards List: How Many Are Global Health?

This data note analyzes the list of terminated and active awards the Trump Administration recently sent to Congress highlighting to assess the impact on global health awards.

An Update on PEPFAR Reauthorization

Overview of President Trump’s Executive Actions on Global Health

The Trump Administration’s Foreign Aid Freeze and Global Health: The Biggest Gaps Left on the Donor Landscape

The Pause of Foreign Aid and Implications for PEPFAR and Other Global Health Programs

selected resources

Global Health Aid Cuts

This collection of resources chronicles what recent Trump administration global health aid cuts mean for the future of global health programs and the people who rely on them.

A promotional image for the the KFF Health Policy 101 U.S. Government and Global Health

The U.S. Government and Global Health

In this Health Policy 101 chapter, investigate the U.S. role in global health, including the major initiatives the United States supports, funding levels, and agencies involved in implementing program area efforts.

the essentials
global health trackers

Latest News

More KFF Health News

Subscribe to KFF Emails

Choose which emails are best for you.
Sign up here

View the Latest: Global Health Policy

Filter

List Grid

141 - 150 of 616 Results

  • The U.S. Congress and Global Health: A Primer

    Report

    This primer provides an overview of congressional engagement in global health. It examines the structure of Congress and its role and key activities in global health. It then illustrates these by examining two global health examples: the creation and evolution of PEPFAR and the 2014/2015 Ebola outbreak in West Africa.

  • Assessing PEPFAR’s Impact: Analysis of Mortality in PEPFAR Countries

    Issue Brief

    As the PEPFAR program approaches its two-decade mark, this new analysis finds the program was associated with large declines in mortality in PEPFAR recipient countries since its creation in 2003, suggesting that future investments will continue to yield significant health impacts.

  • Tracking U.S. COVID-19 Vaccine Donations

    Issue Brief

    This analysis assesses U.S. COVID-19 vaccine dose donations in order to gauge progress towards meeting stated global vaccination goals.

  • Tracking Global COVID-19 Vaccine Equity: An Update

    Issue Brief

    This updated analysis looks at global COVID-19 vaccination efforts by income-level and region to assess the equity gap in both vaccination coverage and rates of administration. Overall, we find that low-income countries and countries in Africa are lagging behind, and based on current rates, are unlikely to meet global vaccination targets.

  • Key Issues and Questions for PEPFAR’s Future

    Issue Brief

    This brief explores key issues and poses questions regarding PEPFAR’s future, providing a roadmap for the major decisions ahead for the program. It identifies eight key, interrelated issues facing the administration, Congress, and other PEPFAR stakeholders.

  • Tracking Global COVID-19 Vaccine Equity

    Issue Brief

    This analysis looks at global COVID-19 vaccination efforts by income-level and region to assess the equity gap in both vaccination coverage and rates of administration. Overall, we find that low-income countries and countries are lagging behind, and based on current rates, are unlikely to meet global vaccination targets.